379 related articles for article (PubMed ID: 16878455)
1. Rabies: epidemiological tendencies and control tools.
Tordo N; Bahloul C; Jacob Y; Jallet C; Perrin P; Badrane H
Dev Biol (Basel); 2006; 125():3-13. PubMed ID: 16878455
[TBL] [Abstract][Full Text] [Related]
2. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
Rupprecht CE; Hanlon CA; Slate D
Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
[TBL] [Abstract][Full Text] [Related]
3. [Viruses and bats: rabies and Lyssavirus].
Tordo N; Marianneau MP
Bull Mem Acad R Med Belg; 2009; 164(1-2):7-15; discussion 15-6. PubMed ID: 19718950
[TBL] [Abstract][Full Text] [Related]
4. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
Perrin P; Jacob Y; Desmézières E; Tordo N
Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
[TBL] [Abstract][Full Text] [Related]
5. Rabies and African bat lyssavirus encephalitis and its prevention.
Warrell M
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S47-52. PubMed ID: 20801003
[TBL] [Abstract][Full Text] [Related]
6. Human rabies due to lyssavirus infection of bat origin.
Johnson N; Vos A; Freuling C; Tordo N; Fooks AR; Müller T
Vet Microbiol; 2010 May; 142(3-4):151-9. PubMed ID: 20188498
[TBL] [Abstract][Full Text] [Related]
7. Comment on: 'Rabies and African bat lyssavirus encephalitis and its prevention'.
Briggs DJ; Wilde H; Hemachuda T; Shantavasinkul P; Quiambao B; Sudarshan MK; Madhusudana SN
Int J Antimicrob Agents; 2011 Feb; 37(2):182-3; author reply 183-4. PubMed ID: 21176874
[No Abstract] [Full Text] [Related]
8. Efficacy of rabies biologics against new lyssaviruses from Eurasia.
Hanlon CA; Kuzmin IV; Blanton JD; Weldon WC; Manangan JS; Rupprecht CE
Virus Res; 2005 Jul; 111(1):44-54. PubMed ID: 15896401
[TBL] [Abstract][Full Text] [Related]
9. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
[TBL] [Abstract][Full Text] [Related]
10. [Bat rabies in Europe and the Czech Republic].
Helesic J; Bartonícka T; Krbková L
Klin Mikrobiol Infekc Lek; 2007 Jun; 13(3):93-8. PubMed ID: 17703400
[TBL] [Abstract][Full Text] [Related]
11. Rabies prophylaxis in Western Australia: the impact of Australian bat lyssavirus.
Torvaldsen S; Watson T
Commun Dis Intell; 1998 Aug; 22(8):149-52. PubMed ID: 9735544
[TBL] [Abstract][Full Text] [Related]
12. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
[TBL] [Abstract][Full Text] [Related]
13. Control and prevention of rabies in animals: paradigm shifts.
Rupprecht CE; Hanlon CA; Slate D
Dev Biol (Basel); 2006; 125():103-11. PubMed ID: 16878466
[TBL] [Abstract][Full Text] [Related]
14. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
[TBL] [Abstract][Full Text] [Related]
15. Bats and lyssaviruses.
Banyard AC; Hayman D; Johnson N; McElhinney L; Fooks AR
Adv Virus Res; 2011; 79():239-89. PubMed ID: 21601050
[TBL] [Abstract][Full Text] [Related]
16. Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?
Evans JS; Horton DL; Easton AJ; Fooks AR; Banyard AC
Vaccine; 2012 Dec; 30(52):7447-54. PubMed ID: 23084854
[TBL] [Abstract][Full Text] [Related]
17. WHO Expert Consultation on rabies.
World Health Organ Tech Rep Ser; 2005; 931():1-88, back cover. PubMed ID: 16485446
[TBL] [Abstract][Full Text] [Related]
18. Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains.
Malerczyk C; Selhorst T; Tordo N; Moore S; Müller T
Vaccine; 2009 Aug; 27(39):5320-5. PubMed ID: 19615958
[TBL] [Abstract][Full Text] [Related]
19. Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines.
Desmézières E; Jacob Y; Saron MF; Delpeyroux F; Tordo N; Perrin P
J Gen Virol; 1999 Sep; 80 ( Pt 9)():2343-2351. PubMed ID: 10501486
[TBL] [Abstract][Full Text] [Related]
20. Emerging aspects of rabies infection: with a special emphasis on children.
Warrell MJ
Curr Opin Infect Dis; 2008 Jun; 21(3):251-7. PubMed ID: 18448969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
